TCBPW Issuance Of Capital Stock from 2010 to 2024

TCBPW Stock  USD 0.02  0  24.67%   
TC BioPharm Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock will likely drop to about 3.3 M in 2024. During the period from 2010 to 2024, TC BioPharm Issuance Of Capital Stock regression line of quarterly data had mean square error of 758.3 B and geometric mean of  2,787,039. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
4.2 M
Current Value
3.3 M
Quarterly Volatility
839.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TC BioPharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TC BioPharm's main balance sheet or income statement drivers, such as Interest Income of 1.9 K, Depreciation And Amortization of 638 K or Interest Expense of 78.9 K, as well as many indicators such as Price To Sales Ratio of 0.62, Dividend Yield of 0.0 or PTB Ratio of 0.3. TCBPW financial statements analysis is a perfect complement when working with TC BioPharm Valuation or Volatility modules.
  
Check out the analysis of TC BioPharm Correlation against competitors.

Latest TC BioPharm's Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of TC BioPharm plc over the last few years. It is TC BioPharm's Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TC BioPharm's overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Very volatile
   Issuance Of Capital Stock   
       Timeline  

TCBPW Issuance Of Capital Stock Regression Statistics

Arithmetic Mean3,093,021
Geometric Mean2,787,039
Coefficient Of Variation27.13
Mean Deviation374,388
Median3,138,131
Standard Deviation839,204
Sample Variance704.3B
Range3.9M
R-Value(0.01)
Mean Square Error758.3B
R-Squared0.0002
Significance0.96
Slope(2,616)
Total Sum of Squares9.9T

TCBPW Issuance Of Capital Stock History

20243.3 M
20234.2 M
20223.4 M
2021285.1 K
20203.9 M

About TC BioPharm Financial Statements

TC BioPharm investors use historical fundamental indicators, such as TC BioPharm's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TC BioPharm. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock4.2 M3.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.